Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chetan Pandit

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Scientific Reports|April 20, 2024
The changing epidemiology of pulmonary infection in children and adolescents with cystic fibrosis: an 18-year experienceJagdev Singh, Sharon Hunt, Sharon Simonds, et al.
Journal of Basic Microbiology|July 15, 2024
Deciphering the Mechanisms and Biotechnological Implications of Nanoparticle Synthesis Through Microbial ConsortiaVandana Singh, Chetan Pandit, Soumya Pandit, et al.
The Science of the Total Environment|February 19, 2022
Use of biomass-derived biochar in wastewater treatment and power production: A promising solution for a sustainable environmentMeenal Gupta, Nishit Savla, Chetan Pandit, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2006
Identification of a novel boron-containing antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseasesStephen J Baker, Tsutomu Akama, Yong-Kang Zhang, et al.
Journal of Medicinal Chemistry|August 23, 2013
Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomniaClaudia Betschart, Samuel Hintermann, Dirk Behnke, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs)Dirk Behnke, Simona Cotesta, Samuel Hintermann, et al.
American Journal of Medical Genetics. Part A|June 9, 2019
Glibenclamide treatment in a Cantú syndrome patient with a pathogenic ABCC9 gain-of-function variant: Initial experienceAlan Ma, Sunita Gurnasinghani, Edwin P Kirk, et al.
Thorax|June 24, 2025
Day-to-day variability indices improve utility of oscillometry in paediatric asthmaMinh Trang Hoang, Alexander Wong, Kate Hardaker, et al.
Paediatric Respiratory Reviews|September 12, 2020
Transition to adult care in cystic fibrosis: The challenges and the structureJagdev Singh, Susan Towns, Geshani Jayasuriya, et al.
Journal of Medicinal Chemistry|August 15, 2014
3-alkoxy-pyrrolo[1,2-b]pyrazolines as selective androgen receptor modulators with ideal physicochemical properties for transdermal administrationThomas Ullrich, Sanjita Sasmal, Venkatesham Boorgu, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Scientific Reports|April 20, 2024
The changing epidemiology of pulmonary infection in children and adolescents with cystic fibrosis: an 18-year experienceJagdev Singh, Sharon Hunt, Sharon Simonds, et al.
Journal of Basic Microbiology|July 15, 2024
Deciphering the Mechanisms and Biotechnological Implications of Nanoparticle Synthesis Through Microbial ConsortiaVandana Singh, Chetan Pandit, Soumya Pandit, et al.
The Science of the Total Environment|February 19, 2022
Use of biomass-derived biochar in wastewater treatment and power production: A promising solution for a sustainable environmentMeenal Gupta, Nishit Savla, Chetan Pandit, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2006
Identification of a novel boron-containing antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseasesStephen J Baker, Tsutomu Akama, Yong-Kang Zhang, et al.
Journal of Medicinal Chemistry|August 23, 2013
Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomniaClaudia Betschart, Samuel Hintermann, Dirk Behnke, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs)Dirk Behnke, Simona Cotesta, Samuel Hintermann, et al.
American Journal of Medical Genetics. Part A|June 9, 2019
Glibenclamide treatment in a Cantú syndrome patient with a pathogenic ABCC9 gain-of-function variant: Initial experienceAlan Ma, Sunita Gurnasinghani, Edwin P Kirk, et al.
Thorax|June 24, 2025
Day-to-day variability indices improve utility of oscillometry in paediatric asthmaMinh Trang Hoang, Alexander Wong, Kate Hardaker, et al.
Paediatric Respiratory Reviews|September 12, 2020
Transition to adult care in cystic fibrosis: The challenges and the structureJagdev Singh, Susan Towns, Geshani Jayasuriya, et al.
Journal of Medicinal Chemistry|August 15, 2014
3-alkoxy-pyrrolo[1,2-b]pyrazolines as selective androgen receptor modulators with ideal physicochemical properties for transdermal administrationThomas Ullrich, Sanjita Sasmal, Venkatesham Boorgu, et al.
Pageof 4